Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Ewing sarcoma/PNET
Stage/Subtype:  localized Ewing sarcoma/PNET
Trial Type:  Treatment
Trial Status:  Active
Results 1-18 of 18 for your search:
Start Over
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: CDR0000068608, EURO-EWING-INTERGROUP-EE99, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, EU-20213, AEWS0331, NCT00020566
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 6 months to 21 years
Sponsor: Other
Protocol IDs: CWS-2007-HR, 4033024 (BfArM), 293/2007AMG1 (Ethikkommission), 2007-001478-10, A2007/14 (Kinderkrebsstiftung), 498 (Krebsstudienregister), NCT00876031
Study in Localized and Disseminated Ewing Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 4 to 50
Sponsor: Other
Protocol IDs: 108128, EudraCT number: 2008-003658-13, NCT00987636
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906
Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCHE-BoneT002, NCT01734863
Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and younger
Sponsor: Other
Protocol IDs: ISG/AIEOP EW-1, NCT02063022
Postoperative Bleeding Prevention in Massive Bone Tumour Resection: a Multicentric, Randomized, Parallel, Controlled Trial
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IIBSP-EVI-2011-138, EC11-340, 2011-006276-40, NCT02153593
Study to Investigate the Safety and Activity of Aldoxorubicin Plus Ifosfamide/Mesna in Subjects With Metastatic Soft Tissue Sarcoma
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 15 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALDOXORUBICIN-P1/2-STS-03, NCT02235701
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Phase: Phase II
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: 05-326, Other, NCT00592293
Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults
Phase: Phase II
Type: Treatment
Status: Active
Age: 40 and under
Sponsor: Other
Protocol IDs: GEIS-21, 2009-016027-62, NCT01696669
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: CR0113061, NCT01807468
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 40
Sponsor: Other
Protocol IDs: 13-068, NCT01864109
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
Phase: Phase II
Type: Treatment
Status: Active
Age: 25 and under
Sponsor: Other
Protocol IDs: ESFT13, NCT01946529
Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01927, CABONE, 9620, NCT02243605
Navigation Surgery for Bone and Soft Tissue Tumor
Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2008-08-058, NCT01179698
Effect of High Doses of Radiation on Bone Structure and Metabolism
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 14-208, C06CA059267, NCT02323295
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 1 to 30
Sponsor: Other
Protocol IDs: 001, NCT02446431
Start Over